Edition:
United Kingdom

Infinity Pharmaceuticals Inc (INFI.OQ)

INFI.OQ on NASDAQ Stock Exchange Global Select Market

1.80USD
15 Dec 2017
Change (% chg)

$-0.03 (-1.64%)
Prev Close
$1.83
Open
$1.84
Day's High
$1.89
Day's Low
$1.78
Volume
396,701
Avg. Vol
402,973
52-wk High
$3.84
52-wk Low
$0.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 6.00 -0.140
Jun '17 0.00 -0.336
Mar '17 0.00 -0.208
FY 2016 Dec '16 0.00 -0.458
Sep '16 0.00 -0.393
Jun '16 9.47 1.072
Mar '16 9.26 -0.824
FY 2015 Dec '15 9.08 -0.796
Sep '15 90.74 0.838
Jun '15 4.88 -0.783
Mar '15 4.36 -1.906
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.00 0.00 0.00 29.40
Quarter Ending Mar-18 2 14.85 29.70 0.00 --
Year Ending Dec-17 4 19.25 65.00 0.00 47.42
Year Ending Dec-18 4 29.67 118.70 0.00 8.44
Earnings (per share)
Quarter Ending Dec-17 4 -0.25 -0.22 -0.27 -0.22
Quarter Ending Mar-18 3 -0.43 -0.27 -0.73 --
Year Ending Dec-17 4 -0.93 -0.90 -0.95 -1.31
Year Ending Dec-18 4 -1.57 -1.04 -2.93 -1.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.76 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta 2.69 0.85 0.88
Price to Sales (TTM) -- 100.68 5.40
Price to Book (MRQ) 1.36 13.50 5.38
Price to Tangible Book (MRQ) 1.37 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 71.60 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 433.86 9.00
Sales (TTM) vs TTM 1 Yr. Ago -100.00 75.04 5.38
Sales - 5 Yr. Growth Rate -27.39 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -131.35 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -581.56 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -15.59 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 6.29 5.36 2.98
LT Debt to Equity (MRQ) 35.31 18.92 11.56
Total Debt to Equity (MRQ) 36.09 20.59 15.81
Interest Coverage (TTM) -- -112.21 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -146.16 -261.12 15.24
Operating Margin (TTM) -- -556.66 7.76
Operating Margin - 5 Yr. Avg. -101.91 -279.30 10.75
Pre-Tax Margin (TTM) -- -529.90 8.57
Pre-Tax Margin - 5 Yr. Avg. -104.77 -279.03 11.17
Net Profit Margin (TTM) -- -531.35 4.88
Net Profit Margin - 5 Yr. Avg. -104.92 -282.21 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,315,636 864,680,397
Net Income/Employee (TTM) -3,037,261 3,332,197 101,718,341
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.23 -0.77 11.00
Return on Assets - 5 Yr. Avg. -26.43 -0.26 12.43
Return on Investment (TTM) -62.67 2.36 14.46
Return on Investment - 5 Yr. Avg. -30.82 2.98 16.28
Return on Equity (TTM) -78.61 2.96 16.05
Return on Equity - 5 Yr. Avg. -41.07 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -82.83 -- -27.39
EPS (TTM) % 76.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Infinity Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 31.40 26.87 91 53
13 Week 5.30 0.17 65 60
26 Week -34.30 -39.29 20 69
52 Week 3.25 -12.49 54 46
YTD 17.78 3.43 60 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.30%
# of Holders: 88
Total Shares Held: 29,553,852
3 Mo. Net Change: -6,521,357
# New Positions: 6
# Closed Positions: 23
# Increased Positions: 23
# Reduced Positions: 49
# Net Buyers: -26
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.